Cambridge, Massachusetts, United States Funds with similar focus
| Fund Name | Location |
| Adventures Lab | Kyiv, Ukraine, Київська міська громада |
| Antares Capital | Florida, Miami, United States |
| Aviva Ventures | England, London, United Kingdom |
| Bohai Securities | - |
| Cherry Tree Investments | California, Los Angeles, United States |
| DIP Capital | England, London, United Kingdom |
| Dongpingheng Investment | - |
| Eatable Adventures | Community of Madrid, Madrid, Spain |
| Fasken Martineau | British Columbia, Canada, Vancouver |
| Gilbert + Tobin | Australia, New South Wales, Sydney |
| Grape Arbor VC | New York, New York, United States |
| Home Capital Group | Canada, Ontario, Toronto |
| JVP Cyber Labs | Be'er Sheva, HaDarom, Israel |
| Oqu Wenhua | China, Shanghai |
| Overkill Ventures | Latvia, Riga, Vidzeme |
| Robi Axiata Limited | - |
| Second Technology Capital Investors | Arizona, Phoenix, United States |
| Sverica Capital | Boston, Massachusetts, United States |
| TiE Pune | California, Santa Clara, United States |
| Yinhe Ruida | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Scorpion Therapeutics | $108M | 26 Oct 2020 | Boston, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Scorpion Therapeutics | $108M | 26 Oct 2020 | Boston, Massachusetts, United States |
